⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Norflurane SCHEMBL3953734 | 0.85 | — | — | |
| SCHEMBL6284827 | 0.77 | — | — | |
| SCHEMBL29077352 | 0.77 | — | — | |
| SCHEMBL9345901 | 0.72 | — | — | |
| SCHEMBL8766236 | 0.72 | — | — | |
| SCHEMBL9493379 | 0.69 | — | — | |
| SCHEMBL9391444 | 0.69 | — | — | |
| SCHEMBL5376470 | 0.67 | — | — | |
| SCHEMBL8968616 | 0.67 | — | — | |
| SCHEMBL6359912 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3322 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220202699-A1 | COMPOSITIONS FOR THE TREATMENT OF VIRAL PULMONARY INFECTIONS | STROHECKER PAUL (US) | 2022-06-30 | — | — | US | claimed |
| US-20220202700-A1 | COMPOSITIONS FOR THE TREATMENT OF VIRAL PULMONARY INFECTIONS | STROHECKER PAUL (US) | 2022-06-30 | — | — | US | claimed |
| EP-4747218-A1 | METHODS, COMPOSITIONS AND USES RELATED TO THE TREATMENT AND PREVENTION OF LEIGH'S SYNDROME | Stealth BioTherapeutics Inc. (US) | 2026-05-27 | — | — | EP | disclosed |
| WO-2026107328-A1 | AGONISTS OF PARATHYROID HORMONE 1 AND INCRETIN RECEPTORS | SEPTERNA, INC. (US) | 2026-05-21 | — | — | WO | disclosed |
| US-12630632-B2 | Bispecific HER2 and CD3 binding molecules | MEMORIAL SLOAN KETTERING CANCER CENTER (US) | 2026-05-19 | — | — | US | disclosed |
| EP-4731237-A1 | COMBINATION THERAPY FOR THE TREATMENT OF FRIEDREICH'S ATAXIA | Stealth BioTherapeutics Inc. (US) | 2026-04-29 | — | — | EP | disclosed |
| US-12612420-B2 | Arginase inhibitors and methods of use thereof | MOLECURE S.A. (PL) | 2026-04-28 | — | — | US | disclosed |
| US-20260109711-A1 | MACROCYCLIC SULFONAMIDE MODULATORS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2026-04-23 | — | — | US | disclosed |
| US-12595244-B2 | Small molecule inhibitors of mammalian SLC6A19 function | JNANA THERAPEUTICS INC. (US) | 2026-04-07 | — | — | US | disclosed |
| US-20260083714-A1 | DOSING REGIMEN FOR TREATING PKU WITH A PIPERIDINE INHIBITOR OF SLC6A19 FUNCTION | JNANA THERAPEUTICS INC (US) | 2026-03-26 | — | — | US | disclosed |
| EP-4215194-B1 | COMBINATION THERAPY OF AT1 R BLOCKER AND CCR2 INHIBITOR FOR THE TREATMENT, AMELIORATION OR PREVENTION OF A KIDNEY DISEASE | DIMERIX BIOSCIENCE PTY LTD (AU) | 2026-03-25 | — | — | EP | disclosed |
| WO-1994020069-A1 | PULMONARY ADMINISTRATION OF GRANULOCYTE COLONY STIMULATING FACTOR | AMGEN INC. (US) | 1994-09-15 | — | — | WO | disclosed |
| EP-0613683-A1 | Pharmaceutical compositions for systemic administration of erythropoietin via the respiratory system | AMGEN INC. (US) | 1994-09-07 | — | — | EP | disclosed |
| WO-1994017822-A1 | PULMONARY ADMINISTRATION OF sCR1 AND OTHER COMPLEMENT INHIBITORY PROTEINS | T CELL SCIENCES, INC. (US) | 1994-08-18 | — | — | WO | disclosed |
| WO-1994017784-A1 | PULMONARY ADMINISTRATION OF ERYTHROPOIETIN | AMGEN INC. (US) | 1994-08-18 | — | — | WO | disclosed |
| US-5284656-A | Directing neutrophil stimulating amount of G CSF into mouth while inhaling | AMGEN INC. (US) | 1994-02-08 | — | — | US | disclosed |
| CN-1066192-A | The pulmonary administration of granulocyte colony stimulating factor (G-CSF) | AMGEN INC (US) | 1992-11-18 | — | — | CN | disclosed |
| WO-1992016192-A1 | PULMONARY ADMINISTRATION OF GRANULOCYTE COLONY STIMULATING FACTOR | AMGEN INC. (US) | 1992-10-01 | — | — | WO | disclosed |
| EP-0505123-A1 | Pulmonary administration of granulocyte colony stimulating factor | AMGEN INC. (US) | 1992-09-23 | — | — | EP | disclosed |
| US-4289893-A | 2,5-Inter-O-phenylene-3,4-dinor-PGF2 compounds | THE UPJOHN COMPANY (US) | 1981-09-15 | — | — | US | disclosed |